Gastro-oesophageal Reflux Disease Trial, Recruiting NCT06746623 Sponsor: Louis Stokes VA Medical Center Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT06746623
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 41 and 84 years old who have never had an upper digestive tract camera examination (endoscopy) before and are able to give written consent to participate
  • People who do not have ongoing heartburn or reflux symptoms and are not taking any regular medication for acid reflux or GERD
  • People who meet medical guideline criteria for Barrett's esophagus screening, meaning they have at least three of the following risk factors: being white, having a BMI over 30 (obesity), being male, currently smoking or having smoked more than 10 pack-years, having a family history of Barrett's esophagus or esophageal cancer, having a waist size over 35 inches (women) or 40 inches (men), or having at least two family members with confirmed Barrett's esophagus or esophageal cancer (with at least one being a close relative)
  • People who do not have a known bleeding disorder, are not taking regular blood-thinning medications, and do not have known varicose veins in the esophagus
  • People who do not have significant trouble swallowing or pain when swallowing

Who may not be able to join:

  • People who have had an upper digestive tract camera examination (endoscopy) within the past ten years
  • People who are unable to provide written informed consent
  • People who have had heartburn or regurgitation once a week or more for five or more years
  • People who are on blood-thinning medications that cannot be safely stopped temporarily, or who have a bleeding disorder with certain abnormal blood test results (INR above 1.5)
  • People with a known history of varicose veins in the esophagus or a narrowing of the esophagus (stricture)
  • People for whom the treating investigator determines there is any medical reason that makes the study procedures unsafe, including conditions such as pouches in the esophagus (diverticula), an abnormal opening in the esophagus (fistula), or esophageal ulcers
  • People with a history of difficulty swallowing or painful swallowing, including difficulty swallowing pills
  • People with a tumour in the throat or mouth area
  • People who have had surgery on the esophagus or stomach, except for certain uncomplicated reflux surgery where normal acid levels have been confirmed afterward (confirm with trial site)
  • People who have had a heart attack or stroke within the past six months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katarina B Greer, MD/MS, Cleveland VA Research and Education Foundation

Phone: 216-791-3800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Louis Stokes VA Medical Center
Registry
ClinicalTrials.gov
Start date
11 April 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Esoguard assay and histology confirming diagnosis of Barrett's esophagus and/or esophageal adenocarcinoma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov